Cavion, LLC. (Cavion)

Oncology Corporate Profile

HQ Location

600 East Water Street, Suite E
Charlottesville, VA 22902

Company Description

Cavion LLC, founded as Tau Therapeutics LLC, is a privately held clinical stage platform pharmaceutical company creating therapies engaging the T-type calcium channel (Cav3) for the treatment of neurologic and oncologic diseases. The T-type calcium channel is an emerging molecular target for cancer and pain.

Website: http://www.cavionpharma.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
miberfradil (+ temozolomide)T-type calcium channel blockerGlioblastoma Multiforme (GBM)I
mibefradilT-type calcium channel blockerGlioblastoma Multiforme (GBM)I
TTL-1177 (+ temosolomide)T-type calcium channel blockerBrain cancerPreclinical
TTL-1177 (+ carboplatinT-type calcium channel blockerOvarian cancerPreclinical
miberfradil (+ carboplatin)T-type calcium channel blockerOvarian cancerPreclinical
miberfradil (+ gemcitabine)T-type calcium channel blockerPancreatic cancerPreclinical

View additional information on product candidates here »

Pipeline image

Source


http://www.cavionpharma.com/

Recent News Headlines

There are no news items to display